Detalles de la búsqueda
1.
Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancers.
Breast Cancer Res
; 26(1): 29, 2024 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38374113
2.
HER2-Low Breast Cancer: Incidence, Clinicopathologic Features, and Survival Outcomes From Real-World Data of a Large Nationwide Cohort.
Mod Pathol
; 36(4): 100087, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788086
3.
Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study.
Mod Pathol
; 36(1): 100009, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788064
4.
The Use of Pan-Tropomyosin Receptor Kinase Immunohistochemistry as a Screening Tool for the Detection of Neurotrophic Tropomyosin-Related Kinase Fusions: Real-World Data from a National Multicentric Retrospective Study.
Pathobiology
; 89(6): 393-406, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35350025
5.
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete response: the IVITA study.
Mod Pathol
; 34(12): 2130-2140, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34218258
6.
A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast.
Int J Cancer
; 146(5): 1189-1197, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31018242
7.
Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent.
Mod Pathol
; 33(9): 1773-1782, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32341499
8.
Ductal carcinoma in situ of the breast: immune cell composition according to subtype.
Mod Pathol
; 33(2): 196-205, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31375764
9.
Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.
Mod Pathol
; 33(3): 354-366, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31534203
10.
Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer.
Ann Diagn Pathol
; 49: 151634, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32987254
11.
Corrigendum to "HER2-Low Breast Cancer: Incidence, Clinicopathologic Features, and Survival Outcomes From Real-World Data of a Large Nationwide Cohort" [Modern Pathology 36(4) 100087].
Mod Pathol
; 36(12): 100356, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37951019
12.
Comment on: "Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project".
Br J Cancer
; 124(8): 1461-1462, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33589774
13.
Correction: Immune response and stromal changes in ductal carcinoma in situ of the breast are subtype dependent.
Mod Pathol
; 34(5): 1039-1040, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33122801
14.
HER2 protein overexpression in non-amplified ductal carcinoma in situ: quality issue or transcription mechanisms gone awry?
Histopathology
; 74(4): 666-668, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30480328
15.
HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study.
Pathology
; 56(3): 334-342, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38341307
16.
Predictive markers for pathological complete response (pCR) after neo-adjuvant chemotherapy in HER2-positive breast carcinoma.
Histol Histopathol
; 39(2): 153-164, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37204204
17.
Breast-implant Related Silicone Lymphadenopathy: Asteroid Bodies do not Always Equal Sarcoidosis!
Int J Surg Pathol
; 31(6): 1099-1104, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36314437
18.
Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine.
Cancers (Basel)
; 14(16)2022 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36010869
19.
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma.
J Pathol Clin Res
; 8(2): 191-205, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34889530
20.
Nuclear Insulinoma-Associated Protein 1 Expression as a Marker of Neuroendocrine Differentiation in Neoplasms of the Breast.
Int J Surg Pathol
; 29(5): 496-502, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33426999